| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $861.3M | -5.2% |
| Cost of Revenue | $690.1M | -4.0% |
| R&D Expense | $62.5M | -13.4% |
| SG&A Expense | $125.6M | +6.9% |
| Operating Income | -$38.6M | — |
| Pre-tax Income | -$55.5M | -307.8% |
| Income Tax | $47.4M | +1518.8% |
| Net Income | -$102.8M | -522.3% |
| EPS (Basic) | -$3.70 | -516.7% |
| EPS (Diluted) | -$3.70 | -516.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $66.3M | -7.8% |
| Accounts Receivable | $131.4M | -4.6% |
| Inventory | $132.7M | -12.3% |
| Current Assets | $361.9M | -6.6% |
| Total Assets | $551.2M | -11.3% |
| Current Liabilities | $157.6M | +5.1% |
| Long-term Debt | $180.9M | -10.2% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $34.0M | -28.7% |
| Investing Cash Flow | -$21.8M | +10.8% |
| Financing Cash Flow | -$25.3M | -327.5% |
| $179.8M |
| -26.7% |